ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 125 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $478,000 | +3314.3% | 25,332 | +2061.4% | 0.00% | – |
| Q2 2019 | $14,000 | +55.6% | 1,172 | +74.4% | 0.00% | – |
| Q1 2019 | $9,000 | -82.4% | 672 | -86.4% | 0.00% | – |
| Q4 2018 | $51,000 | -50.0% | 4,955 | -19.5% | 0.00% | -100.0% |
| Q3 2018 | $102,000 | +21.4% | 6,155 | +16.0% | 0.00% | 0.0% |
| Q2 2018 | $84,000 | -25.0% | 5,308 | -40.0% | 0.00% | 0.0% |
| Q1 2018 | $112,000 | +34.9% | 8,845 | +21.5% | 0.00% | 0.0% |
| Q4 2017 | $83,000 | -75.1% | 7,277 | -73.3% | 0.00% | -66.7% |
| Q3 2017 | $334,000 | +17.2% | 27,297 | +9.7% | 0.00% | 0.0% |
| Q2 2017 | $285,000 | – | 24,893 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 229,895 | $7,593,000 | 6.73% |
| Foresite Capital Management II, LLC | 419,997 | $13,873,000 | 4.65% |
| Cormorant Asset Management, LP | 757,475 | $25,019,000 | 2.99% |
| NEXTHERA CAPITAL LP | 60,000 | $1,982,000 | 2.81% |
| SENZAR ASSET MANAGEMENT, LLC | 557,170 | $18,403,325,000 | 2.05% |
| Parametrica Management Ltd | 9,360 | $309,000 | 2.04% |
| Partner Investment Management, L.P. | 36,756 | $1,214,000 | 1.99% |
| PFM Health Sciences, LP | 1,890,030 | $62,428,000 | 1.90% |
| PYRRHO CAPITAL MANAGEMENT, LP | 63,000 | $2,081,000 | 1.40% |
| BB BIOTECH AG | 1,510,150 | $49,880,000 | 1.40% |